PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli

Infection and Immunity

Volumn 82, Issue 10, 2014, Pages 4241-4252

  Baum, Mordechai ^a   Watad, Mobarak ^a   Smith, Sara N ^b   Alteri, Christopher J ^b   Gordon, Noa ^a   Rosenshine, Ilan ^a   Mobley, Harry L ^b   Amster Choder, Orna ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAFR TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; GLUCOSE TRANSPORTER; PAFP PROTEIN, E COLI; PAFR PROTEIN, E COLI; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BIOFILM; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENOME; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; CBA MOUSE; DISEASE MODEL; ESCHERICHIA COLI INFECTION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; LOCOMOTION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; VIRULENCE;

ANIMALS; BIOFILMS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC COMPLEMENTATION TEST; LOCOMOTION; MICE; MICE, INBRED CBA; MICROARRAY ANALYSIS; MONOSACCHARIDE TRANSPORT PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE; VIRULENCE FACTORS;

EID: 84907093523     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00086-14     Document Type: Article

References (64)

1. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11-19. http://dx.doi.org/10.1016/j.yexmp.2008.03.007.
2. Foxman B. 2010. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7:653-660. http://dx.doi.org/10.1038/nrurol.2010.190.
3. Mobley H, Warren J. 1996. Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, DC.
4. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD, Warren JW. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
5. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272. http://dx.doi.org/10.1086 /315217.
6. Johnson JR, Stell AL, Delavari P, Murray AC, Kuskowski M, Gaastra W. 2001. Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans. J. Infect. Dis. 183:897-906. http://dx.doi.org/10.1086/319263.
7. Kao JS, Stucker DM, Warren JW, Mobley HL. 1997. Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains. Infect. Immun. 65:2812-2820.
8. Welch RA, Burland V, Plunkett G, III, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HL, Donnenberg MS, Blattner FR. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024. http://dx.doi.org/10.1073/pnas.252529799.
9. Lloyd AL, Rasko DA, Mobley HL. 2007. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J. Bacteriol. 189:3532-3546. http://dx.doi.org/10.1128/JB.01744-06.
10. Lloyd AL, Henderson TA, Vigil PD, Mobley HL. 2009. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J. Bacteriol. 191: 3469-3481. http://dx.doi.org/10.1128/JB.01717-08.
11. Guyer DM, Kao JS, Mobley HL. 1998. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples. Infect. Immun. 66:4411-4417.
12. Houman F, Diaz-Torres MR, Wright A. 1990. Transcriptional antitermination in the bgl operon of E. coli is modulated by a specific RNA binding protein. Cell 62:1153-1163. http://dx.doi.org/10.1016/0092-8674 (90)90392-R.
13. van Tilbeurgh H, Declerck N. 2001. Structural insights into the regulation of bacterial signalling proteins containing PRDs. Curr. Opin. Struct. Biol. 11:685-693. http://dx.doi.org/10.1016/S0959-440X(01)00267-6.
14. Mahadevan S, Wright A. 1987. A bacterial gene involved in transcription antitermination: regulation at a rho-independent terminator in the bgl operon of E. coli. Cell 50:485-494. http://dx.doi.org/10.1016/0092 -8674(87)90502-2.
15. Amster-Choder O. 2005. The bgl sensory system: a transmembrane signaling pathway controlling transcriptional antitermination. Curr. Opin. Microbiol. 8:127-134. http://dx.doi.org/10.1016/j.mib.2005.02.014.
16. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
17. Mahadevan S, Reynolds AE, Wright A. 1987. Positive and negative regulation of the bgl operon in Escherichia coli. J. Bacteriol. 169:2570- 2578.
18. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
19. Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of urinary pathogens. Lett. Appl. Microbiol. 24:203-206. http://dx.doi.org /10.1046/j.1472-765X.1997.00378.x.
20. Lane MC, Alteri CJ, Smith SN, Mobley HL. 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. U. S. A. 104:16669-16674. http://dx.doi.org/10.1073/pnas.0607898104.
21. Friedberg D, Umanski T, Fang Y, Rosenshine I. 1999. Hierarchy in the expression of the locus of enterocyte effacement genes of enteropathogenic Escherichia coli. Mol. Microbiol. 34:941-952. http://dx.doi.org/10.1046/j.1365-2958.1999.01655.x.
22. Schlosser-Silverman E, Elgrably-Weiss M, Rosenshine I, Kohen R, Altuvia S. 2000. Characterization of Escherichia coli DNA lesions generated within J774 macrophages. J. Bacteriol. 182:5225-5230. http://dx.doi.org/10.1128/JB.182.18.5225-5230.2000.
23. Palaniyandi S, Mitra A, Herren CD, Lockatell CV, Johnson DE, Zhu X, Mukhopadhyay S. 2012. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073. PLoS One 7:e31348. http://dx.doi.org/10.1371/journal.pone.0031348.
24. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
25. O'Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461. http://dx.doi.org/10.1046/j.1365-2958.1998.00797.x.
26. Lane MC, Lockatell V, Monterosso G, Lamphier D, Weinert J, Hebel JR, Johnson DE, Mobley HL. 2005. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 73: 7644-7656. http://dx.doi.org/10.1128/IAI.73.11.7644-7656.2005.
27. Cooper LA, Simmons LA, Mobley HL. 2012. Involvement of mismatch repair in the reciprocal control of motility and adherence of uropathogenic Escherichia coli. Infect. Immun. 80:1969-1979. http://dx.doi.org/10.1128/IAI.00043-12.
28. Collins TJ. 2007. ImageJ for microscopy. Biotechniques 43:25-30. http: //dx.doi.org/10.2144/000112505.
29. Nussbaum-Shochat A, Amster-Choder O. 1999. BglG, the transcriptional antiterminator of the bgl system, interacts with the beta' subunit of the Escherichia coli RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 96: 4336-4341. http://dx.doi.org/10.1073/pnas.96.8.4336.
30. Hagan EC, Mobley HL. 2009. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 71:79-91. http://dx.doi.org/10.1111/j.1365 -2958.2008.06509.x.
31. Quan JA, Schneider BL, Paulsen IT, Yamada M, Kredich NM, Saier MH, Jr. 2002. Regulation of carbon utilization by sulfur availability in Escherichia coli and Salmonella typhimurium. Microbiology 148:123-131.
32. Bochner B. 1993. Advances in the identification of bacteria and yeast. Am. Clin. Lab. 12:6.
33. Mahan MJ, Slauch JM, Mekalanos JJ. 1993. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259:686-688. http://dx.doi.org/10.1126/science.8430319.
34. Thomas S, Holland IB, Schmitt L. 2014. The type 1 secretion pathway- the hemolysin system and beyond. Biochim. Biophys. Acta 1843:1629- 1641. http://dx.doi.org/10.1016/j.bbamcr.2013.09.017.
35. Roncero C, Casadaban MJ. 1992. Genetic analysis of the genes involved in synthesis of the lipopolysaccharide core in Escherichia coli K-12: three operons in the rfa locus. J. Bacteriol. 174:3250-3260.
36. Garofalo CK, Hooton TM, Martin SM, Stamm WE, Palermo JJ, Gordon JI, Hultgren SJ. 2007. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect. Immun. 75:52-60. http://dx.doi.org/10.1128 /IAI.01123-06.
37. Karatan E, Watnick P. 2009. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol. Mol. Biol. Rev. 73:310- 347. http://dx.doi.org/10.1128/MMBR.00041-08.
38. Beloin C, Roux A, Ghigo JM. 2008. Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. 322:249-289.
39. Spurbeck RR, Tarrien RJ, Mobley HL. 2012. Enzymatically active and inactive phosphodiesterases and diguanylate cyclases are involved in regulation of motility or sessility in Escherichia coli CFT073. mBio 3(5): e00307-12. http://dx.doi.org/10.1128/mbio.00307-12.
40. Lang H, Jonson G, Holmgren J, Palva ET. 1994. The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors. Infect. Immun. 62:4781-4788.
41. Kumar SS, Sankaran K, Haigh R, Williams PH, Balakrishnan A. 2001. Cytopathic effects of outer-membrane preparations of enteropathogenic Escherichia coli and co-expression of maltoporin with secretory virulence factor, EspB. J. Med. Microbiol. 50:602-612.
42. Valkonen KH, Veijola J, Dagberg B, Uhlin BE. 1991. Binding of basement-membrane laminin by Escherichia coli. Mol. Microbiol. 5:2133- 2141. http://dx.doi.org/10.1111/j.1365-2958.1991.tb02143.x.
43. Vazquez-Juarez RC, Romero MJ, Ascencio F. 2004. Adhesive properties of a LamB-like outer-membrane protein and its contribution to Aeromonas veronii adhesion. J. Appl. Microbiol. 96:700-708. http://dx.doi.org/10.1111/j.1365-2672.2004.02177.x.
44. Shelburne SA, Davenport MT, Keith DB, Musser JM. 2008. The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci. Trends Microbiol. 16:318 -325. http://dx.doi.org/10.1016/j.tim.2008.04.002.
45. Shelburne SA, III, Keith DB, Davenport MT, Horstmann N, Brennan RG, Musser JM. 2008. Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol. Microbiol. 69:436-452. http://dx.doi.org/10.1111/j.1365-2958.2008.06290.x.
46. Lone AG, Deslandes V, Nash JH, Jacques M, MacInnes JI. 2009. malT knockout mutation invokes a stringent type gene-expression profile in Actinobacillus pleuropneumoniae in bronchoalveolar fluid. BMC Microbiol. 9:195. http://dx.doi.org/10.1186/1471-2180-9-195.
47. Pizarro-Cerda J, Cossart P. 2006. Bacterial adhesion and entry into host cells. Cell 124:715-727. http://dx.doi.org/10.1016/j.cell.2006.02.012.
48. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HL. 2004. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72: 6373-6381. http://dx.doi.org/10.1128/IAI.72.11.6373-6381.2004.
49. Nagy G, Dobrindt U, Schneider G, Khan AS, Hacker J, Emody L. 2002. Loss of regulatory protein RfaH attenuates virulence of uropathogenic Escherichia coli. Infect. Immun. 70:4406-4413. http://dx.doi.org/10.1128 /IAI.70.8.4406-4413.2002.
50. Jain A, Gupta Y, Agrawal R, Khare P, Jain SK. 2007. Biofilms-a microbial life perspective: a critical review. Crit. Rev. Ther. Drug Carrier Syst. 24:393-443. http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v24.i5.10.
51. Povolotsky TL, Hengge R. 2012. 'Life-style' control networks in Escherichia coli: signaling by the second messenger c-di-GMP. J. Biotechnol. 160:10-16. http://dx.doi.org/10.1016/j.jbiotec.2011.12.024.
52. Wood TK. 2009. Insights on Escherichia coli biofilm formation and inhibition from whole-transcriptome profiling. Environ. Microbiol. 11:1-15. http://dx.doi.org/10.1111/j.1462-2920.2008.01768.x.
53. Zhang XS, Garcia-Contreras R, Wood TK. 2007. YcfR (BhsA) influences Escherichia coli biofilm formation through stress response and surface hydrophobicity. J. Bacteriol. 189:3051-3062. http://dx.doi.org/10.1128/JB.01832-06.
54. Barnhart MM, Chapman MR. 2006. Curli biogenesis and function. Annu. Rev. Microbiol. 60:131-147. http://dx.doi.org/10.1146/annurev.micro.60.080805.142106.
55. Kim Y, Wang X, Ma Q, Zhang XS, Wood TK. 2009. Toxin-antitoxin systems in Escherichia coli influence biofilm formation through YjgK (TabA) and fimbriae. J. Bacteriol. 191:1258-1267. http://dx.doi.org/10.1128/JB.01465-08.
56. Donlan RM. 2002. Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8:881-890. http://dx.doi.org/10.3201/eid0809.020063.
57. Pratt LA, Kolter R. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-293. http://dx.doi.org/10.1046/j.1365-2958.1998.01061.x.
58. Genevaux P, Muller S, Bauda P. 1996. A rapid screening procedure to identify mini-Tn10 insertion mutants of Escherichia coli K-12 with altered adhesion properties. FEMS Microbiol. Lett. 142:27-30. http://dx.doi.org /10.1111/j.1574-6968.1996.tb08402.x.
59. Wood TK, Gonzalez Barrios AF, Herzberg M, Lee J. 2006. Motility influences biofilm architecture in Escherichia coli. Appl. Microbiol. Biotechnol. 72:361-367. http://dx.doi.org/10.1007/s00253-005-0263-8.
60. Gauger EJ, Leatham MP, Mercado-Lubo R, Laux DC, Conway T, Cohen PS. 2007. Role of motility and the flhDC operon in Escherichia coli MG1655 colonization of the mouse intestine. Infect. Immun. 75:3315- 3324. http://dx.doi.org/10.1128/IAI.00052-07.
61. Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog. 5:e1000448. http://dx.doi.org/10.1371/journal.ppat.1000448.
62. Eisenreich W, Dandekar T, Heesemann J, Goebel W. 2010. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat. Rev. Microbiol. 8:401-412. http://dx.doi.org/10.1038/nrmicro2351.
63. Stock AM, Robinson VL, Goudreau PN. 2000. Two-component signal transduction. Annu. Rev. Biochem. 69:183-215. http://dx.doi.org/10.1146/annurev.biochem.69.1.183.
64. Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol. Microbiol. 80:1516-1529. http://dx.doi.org/10.1111/j.1365-2958.2011.07660.x.